Shoji Nahoko, Ito Yoshikazu, Kimura Yukihiko, Nishimaki Jiroh, Kuriyama Yuzuru, Tauchi Tetsuzo, Yaguchi Makoto, Payzulla Dilnur, Ebihara Yoshiro, Ohyashiki Kazuma
First Department of Internal Medicine, Tokyo Medical University, 6-7-1 Nishishijuku, Shinjuku-ku, 160-0023, Tokyo, Japan.
Leuk Res. 2002 Jun;26(6):591-5. doi: 10.1016/s0145-2126(01)00178-3.
Secondary pulmonary alveolar proteinosis (PAP) is one of the complications of hematologic malignancy and immunosuppressive diseases. We encountered four cases of myelodysplastic syndrome (MDS) associated with PAP detected on autopsy. They consisted of two refractory anemia (RA) and two patients with refractory anemia with excess blasts in transformation (RAEBt) at the time of MDS diagnosis, but all of them developed leukemic phase and were resistant to chemotherapy at the time of pulmonary episodes. Of the four MDS patients, two also had pulmonary aspergillosis. Previously, 69 patients with PAP associated with hematologic disorders have been reported, but there have been only seven cases with MDS, including our four patients. Of the 69 reported cases of PAP in hematologic malignancies, 24/63 (38%) informative patients with infection had fungal infections of the lung; 2/7 (29%) MDS cases had fungal infection. We should, therefore, pay careful attention to this possibility in cases of MDS with lung complications, including PAP, especially in patients in the leukemic phase of MDS.
继发性肺泡蛋白沉积症(PAP)是血液系统恶性肿瘤和免疫抑制性疾病的并发症之一。我们在尸检中发现了4例与PAP相关的骨髓增生异常综合征(MDS)病例。他们在MDS诊断时包括2例难治性贫血(RA)和2例难治性贫血伴原始细胞过多转化(RAEBt)患者,但在肺部病变时均发展为白血病期且对化疗耐药。在这4例MDS患者中,有2例还患有肺曲霉菌病。此前,已有69例与血液系统疾病相关的PAP患者的报道,但仅有7例MDS患者,包括我们的4例患者。在69例报道的血液系统恶性肿瘤相关PAP病例中,24/63(38%)有感染信息的患者发生了肺部真菌感染;2/7(29%)的MDS病例有真菌感染。因此,对于伴有肺部并发症(包括PAP)的MDS患者,尤其是处于MDS白血病期的患者,我们应密切关注这种可能性。